AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $519,283 | -2.9% | 7,430 | -0.2% | 0.01% | 0.0% |
| Q2 2023 | $534,998 | +15.3% | 7,445 | -1.0% | 0.01% | +20.0% |
| Q1 2023 | $463,834 | -39.4% | 7,520 | -24.3% | 0.01% | -44.4% |
| Q4 2022 | $765,901 | +59.2% | 9,930 | -7.9% | 0.01% | +50.0% |
| Q3 2022 | $481,000 | -17.2% | 10,780 | -29.0% | 0.01% | -14.3% |
| Q2 2022 | $581,000 | -6.4% | 15,180 | +1.1% | 0.01% | 0.0% |
| Q1 2022 | $621,000 | +14.6% | 15,010 | +4.7% | 0.01% | +16.7% |
| Q4 2021 | $542,000 | +0.7% | 14,335 | -12.2% | 0.01% | 0.0% |
| Q3 2021 | $538,000 | -14.6% | 16,325 | +74.9% | 0.01% | -14.3% |
| Q2 2021 | $630,000 | +24.0% | 9,335 | +4.0% | 0.01% | +16.7% |
| Q1 2021 | $508,000 | -13.5% | 8,980 | +24.6% | 0.01% | -33.3% |
| Q4 2020 | $587,000 | +17.6% | 7,205 | +2.9% | 0.01% | 0.0% |
| Q3 2020 | $499,000 | +55.9% | 7,000 | +79.7% | 0.01% | +50.0% |
| Q2 2020 | $320,000 | -12.8% | 3,895 | +9.7% | 0.01% | 0.0% |
| Q4 2019 | $367,000 | – | 3,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |